Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News KORU Medical Systems Inc KRMD

Healthcare
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating... see more

Current News (NDAQ:KRMD)

KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025

Business Wire November 17, 2025

KORU Medical Systems to Participate in Upcoming Investor Conferences

Business Wire November 13, 2025

KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance

Business Wire November 12, 2025

KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems

Business Wire November 4, 2025

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

Business Wire October 22, 2025

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Business Wire September 18, 2025

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

Business Wire August 6, 2025

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 1, 2025

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

Business Wire July 30, 2025
View More News ››

Opinion & Analysis (NDAQ:KRMD)

Could a FDA warning letter provide a silver lining to this home care medical device company?

Streetwise Reports November 7, 2017
View More Opinion ››

Bullboard Posts (NDAQ:KRMD)

Be the first to post on this bullboard.

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »